Hydrochlorothiazide/Nebivolol

氢氯噻嗪/奈必洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Nebivolol

Drug Alias Name奈必洛尔/氢氯噻嗪Hydrochlorothiazide and NebivololNebivolol/HydrochlorothiazideNebivolol / Hydrochlorothiazidenebivolol and hydrochlorothiazide +[8]

ClassificationSmall molecules

Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsBeta-1 adrenergic receptor antagonists

TargetsThiazide-sensitive sodium-chloride cotransporterBeta-1 adrenergic receptor

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Hydrochlorothiazide Nebivolol Hydrochloride

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesMenarini

China Registration ClassN/A

Develop Information

Active CompaniesMenarini Group

Inactive CompaniesN/A

Active IndicationsHypertension

Inactive IndicationsN/A

Other Information

ATC CodeC07BB